Addendum: Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma

Detalles Bibliográficos
Autores principales: Chen, Yongshun, Wu, Xiaoyuan, Hao, Daxuan, Cheng, Xinyu, Zhang, Lei, Zhang, Yougai, Ke, Shaobo, Shi, Wei, He, Chunyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2022
Materias:
Addendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9725978/
https://www.ncbi.nlm.nih.gov/pubmed/36473119
http://dx.doi.org/10.18632/oncotarget.28320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9725978/
https://www.ncbi.nlm.nih.gov/pubmed/36473119
http://dx.doi.org/10.18632/oncotarget.28320

Ejemplares similares